Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors-Reference-Cited by-同舟云学术

Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors

Published:2010-03-10 Issue:2 Volume:1 Page:85-89
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Chen Jianyong¹,Bai Longchuan¹,Bernard Denzil¹,Nikolovska-Coleska Zaneta¹,Gomez Cindy¹,Zhang Jian¹,Yi Han¹,Wang Shaomeng¹

Affiliation:

1. Comprehensive Cancer Center and Departments of Internal Medicine, Pharmacology and Medicinal Chemistry, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, Michigan 48109

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml100010j

Reference27 articles.

1. Transcription factors as targets for cancer therapy

2. The role of STATs in transcriptional control and their impact on cellular function

3. The STATs of cancer — new molecular targets come of age

4. STAT proteins: novel molecular targets for cancer drug discovery

5. STAT3 as a target for inducing apoptosis in solid and hematological tumors

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The JAK-STAT pathway: from structural biology to cytokine engineering;Signal Transduction and Targeted Therapy;2024-08-21

2. The Disulfide Bond-Mediated Cyclization of Oral Peptides;Current Protein & Peptide Science;2024-07

3. Enhancing cancer therapy: The role of drug delivery systems in STAT3 inhibitor efficacy and safety;Life Sciences;2024-06

4. Small molecule drug discovery targeting the JAK-STAT pathway;Pharmacological Research;2024-06

5. Optimization of a Novel DEL Hit That Binds in the Cbl-b SH2 Domain and Blocks Substrate Binding;ACS Medicinal Chemistry Letters;2024-05-29